Site Search
Professionals 510 results
Capabilities 84 results
Practice Area
Our nationally recognized Appellate & Critical Motions (ACM) Practice delivers sophisticated legal advocacy and analysis before trial, at trial, and on appeal. From state trial courts to the U.S. Supreme Court, our ACM attorneys identify, preserve, and present the critical legal issues that can make the difference between winning and losing.
Practice Area
Trial skills matter—even in a world where few disputes ever see the inside of a courtroom. Winston has built a reputation as a trial lawyers’ firm, featuring seasoned litigators who leverage extensive courtroom experience to meet our clients’ business and legal objectives. Our long history of taking cases to trial—and winning—provides our clients with tremendous settlement leverage with their adversaries, as well as a substantial likelihood of a favorable resolution if, and when, they go to trial.
Practice Area
Our attorneys have extensive experience counseling U.S. and multinational public companies across a range of industries in all aspects of corporate governance, securities, and compliance matters. We advise public companies, boards of directors and their committees, and senior executives on the corporate governance and compliance matters that public companies and their leadership confront—from board structuring and succession planning to shareholder activism and SEC regulation. Drawing on our experience as seasoned counselors, we keep clients abreast of evolving trends and best practices to proactively manage any governance or compliance issues. We have assembled one of the most experienced teams of any law firm in the country that’s counseling public companies.
Experience 512 results
Experience
|March 4, 2026
End of the Line: Winston Wins Unanimous Supreme Court Victory Against NJ Transit
In a unanimous decision authored by Justice Sotomayor, the U.S. Supreme Court held that NJ Transit is not an arm of the State of New Jersey and therefore is not entitled to sovereign immunity. The ruling means that plaintiffs injured by NJ Transit outside of New Jersey—such as in Pennsylvania and New York—may pursue claims in the courts of the states where their injuries occurred. The court adopted Winston’s position that state-created corporations that are formally liable for their own judgments are not arms of the state, reversing the Pennsylvania Supreme Court’s dismissal of Cedric Galette’s negligence suit while affirming the New York Court of Appeals’ decision allowing Jeffrey Colt’s case to proceed.
Experience
|February 18, 2026
RF Acquisition Corp III Announces Closing of $100 Million Initial Public Offering
Winston & Strawn LLP represented RF Acquisition Corp III, a newly organized special purpose acquisition company formed as a Cayman Islands exempted company, in connection with its $100M initial public offering. The Company priced 10,000,000 units at a price of $10.00 per unit. The units are listed on the Nasdaq Global Market and began trading under the ticker symbol “RFAMU” on February 13, 2026. Each unit consists of one ordinary share, par value $0.0001 per share, and one right to receive one-tenth of one ordinary share.
Experience
|February 12, 2026
Braiin Ltd. Loan from Streeterville
Winston represented Braiin in a $6.5 million loan from Streeterville.
Insights & News 7,157 results
Seminar/CLE
|March 25, 2026
Sanctions, Arbitration, and Cross-Border Enforcement: Complex Intersections in Practice
We are pleased to host an exclusive panel session during Paris Arbitration Week, exploring the complex intersections of sanctions regimes, international arbitration, and cross-border enforcement. This program combines real-world case insights with comparative perspectives to help practitioners navigate today’s challenging global legal landscape.
Sponsorship
|March 23, 2026
Winston & Strawn Sponsors Healthcare Business International (HBI) 2026
We are proud to be an Elite Sponsor of the 2026 Healthcare Business International Conference in Paris. This must-attend event brings together leading decision-makers from the global for-profit healthcare sector to explore new business opportunities, drive growth, and shape the future of healthcare.
Sponsorship
|March 22, 2026
Winston & Strawn Sponsors 38th Annual Roth Conference
Winston & Strawn is proud to sponsor the 38th Annual Roth Conference. This year, the program will feature one-on-one and small group meetings, analyst-selected fireside chats, industry keynotes, and panel discussions.
Other Results 77 results
Law Glossary
Where Is a List of Biosimilar Drugs and Biologics That Have Been Approved in the U.S.?
The FDA maintains a list of biosimilar drugs that have been approved in the USA. This list can be found here.
Law Glossary
Maintained by the FDA, the Purple Book lists biologic products and biosimilar products that FDA has licensed under the Public Health Service Act. In addition, the Purple Book identifies the date each biologic obtained FDA licensure and indicates whether any biosimilar is interchangeable with its associated reference product.
Site Content
Blockchain is a technological system in which a digital list of records stored across a network. The network is a shared database comprised of a large number of computers. Blockchain is the primary technology for cryptocurrencies.